PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
18451172-4	2008	In contrast, the addition of low-dose TRAIL to nocodazole was associated with maximally increased caspase-3, caspase-8, and caspase-9 activation, which efficiently abrogated the mitotic delay and markedly increased cell death.	Nocodazole	47-57	TNF superfamily member 10	Homo sapiens	38-43	
18451172-6	2008	The addition of TRAIL to either nocodazole or paclitaxel (Taxol) reduced levels of the mitotic checkpoint proteins BubR1 and Bub1.	Nocodazole	32-42	TNF superfamily member 10	Homo sapiens	16-21	
18451172-7	2008	BubR1 mutated for the caspase cleavage sites, but not wild-type BubR1, was resistant to cleavage induced by TRAIL added to nocodazole, and partially blocked the checkpoint abrogation.	Nocodazole	123-133	TNF superfamily member 10	Homo sapiens	108-113	
18393775-4	2008	The microtubule inhibitors taxol, nocodazole, and colcemid, as well as an inhibitor of actin microfilaments cytochalasin D, enhance the action of TRAIL and allow it to overcome protection caused by overexpression of Bcl-2.	Nocodazole	34-44	TNF superfamily member 10	Homo sapiens	146-151	
16229016-8	2006	Conversely, microtubule disruption and Golgi scattering induced with Nocodazole treatment inhibited TRAIL-increased NOS activity, indicating that, on cultured HUVEC, TRAIL ability to affect NO production by regulating eNOS sub-cellular distribution is mediated by cytoskeleton and Golgi complex modifications.	Nocodazole	69-79	TNF superfamily member 10	Homo sapiens	100-105	
16229016-8	2006	Conversely, microtubule disruption and Golgi scattering induced with Nocodazole treatment inhibited TRAIL-increased NOS activity, indicating that, on cultured HUVEC, TRAIL ability to affect NO production by regulating eNOS sub-cellular distribution is mediated by cytoskeleton and Golgi complex modifications.	Nocodazole	69-79	TNF superfamily member 10	Homo sapiens	166-171